Mortality in infarct-related cardiogenic shock (CS) remains high, reaching 40–50%. In refractory CS, active mechanical circulatory support devices including veno-arterial extracorporeal membrane oxygenation (VA-ECMO) are rapidly evolving. However, supporting evidence of VA-ECMO therapy in infarct-related CS is low. The current review aims to give an overview on the basics of VA-ECMO therapy, current evidence, ongoing trials, patient selection and potential complications.
| Identifer | oai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:85730 |
| Date | 02 June 2023 |
| Creators | Freund, Anne, Desch, Steffen, Pöss, Janine, Sulimov, Dmitry, Sandri, Marcus, Majunke, Nicolas, Thiele, Holger |
| Publisher | MDPI |
| Source Sets | Hochschulschriftenserver (HSSS) der SLUB Dresden |
| Language | English |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, doc-type:article, info:eu-repo/semantics/article, doc-type:Text |
| Rights | info:eu-repo/semantics/openAccess |
| Relation | 2077-0383, 1256 |
Page generated in 0.0013 seconds